[Ca 125 in epithelial ovarian cancers of FIGO stage I].
Nagele
F
F
I. Univers.-Frauenklinik Wien.
Kurz
C
C
Vavra
N
N
Sevelda
P
P
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D002277:Carcinoma / Q000401:mortality / Q000473:pathology*; D004848:Epithelium / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000401:mortality / Q000473:pathology*; D010053:Ovary / Q000473:pathology; D015996:Survival Rate
D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor
CA 125 bei epithelialen Ovarialkarzinomen des FIGO-Stadium I.